Table 2 Primary outcome measures for the treatment groups after 12 months
Primary outcome measures | Surgery (n = 73) | Splint (n = 83) | Difference* |
|---|---|---|---|
Success rate (%)** | 92% (67/73) | 72% (60/83) | 20% (8; 31) |
# nights waking up due to complaints (0–7)** | 3.6 (2.9) | 2.9 (3.0) | 0.7 (-0.2; 1.7) |
Severity of the main complaint (0–10)** | 6.4 (2.7) | 5.1 (3.1) | 1.3 (0.4; 2.2) |
Paraesthesia during the day (0–10)** | 5.5 (2.9) | 4.0 (3.4) | 1.5 (0.5; 2.5) |
Paraesthesia at night (0–10)** | 5.2 (3.6) | 4.5 (3.4) | 0.7 (-0.4; 1.8) |
Utility (EuroQol; 0–1)*** | 0.85 (0.12) | 0.81 (0.16) | 0.04 (-0.004; 0.08) |